Variable | GMR± | 95% CI* | Adjusted GMR± | 95% CI* | P |
---|---|---|---|---|---|
Sex | |||||
Men | 1 | 1 | 0.007 | ||
Women | 1.13 | 1.06-1.21 | 1.12 | 1.03-1.22 | |
Age group | |||||
0-5 years | 0.87 | 0.75-0.99 | 1.02 | 0.84-1.24 | 0.526 |
5-15 years | 1.16 | 0.99-1.37 | 1.14 | 0.93-1.39 | |
15-25 years | 1.00 | 0.89-1.23 | 0.93 | 0.81-1.08 | |
25-35 years | 1 | 1 | |||
35-45 years | 1.00 | 0.92-1.08 | 0.96 | 0.87-1.06 | |
≥ 45 years | 1.00 | 0.90-1.10 | 0.96 | 0.84-1.09 | |
Site of HIV test | |||||
QECH | 1 | 1 | |||
Facility other than QECH | 1.65 | 1.54-1.77 | 1.61 | 1.47-1.77 | <0.001 |
Unknown | 1.82 | 1.64-2.02 | 1.93 | 1.66-2.24 | |
WHO stage at registration | |||||
Stage 1 or 2 | 1 | ||||
Stage 3 or 4 | 1.01 | 0.95-1.08 | |||
CD4 count (cells/μl) | |||||
≥ 350 | 1 | 1 | <0.001 | ||
250 – 350 | 0.87 | 0.70-1.11 | 0.96 | 0.75-1.20 | |
50 – 250 | 0.76 | 0.61-0.95 | 0.77 | 0.62-0.98 | |
<50 | 0.50 | 0.40-0.63 | 0.53 | 0.42-0.68 | |
Year of ART initiation | |||||
2004 | 0.92 | 0.75-1.14 | 0.79 | 0.52-1.21 | 0.004 |
2005 | 1 | 1 | |||
2006 | 0.72 | 0.60-0.87 | 0.75 | 0.48-1.16 | |
2007 | 0.64 | 0.55-0.76 | 0.71 | 0.50-1.03 | |
2008 | 0.68 | 0.59-0.80 | 0.72 | 0.51-1.02 | |
2009 | 0.69 | 0.59-0.80 | 0.69 | 0.49-0.99 | |
2010 | 0.75 | 0.64-0.88 | 0.85 | 0.60-1.21 | |
2011 | 0.54 | 0.47-0.63 | 0.84 | 0.59-1.21 | |
Number of ART initiators per year (continuous) | 1.00 | 1.00-1.00 |